Thirteen manic patients were treated with lithium carbonate and ten manic patients with chlorpromazine in a double-blind, randomly selected drug trial. Lithium carbonate proved superior to chlorpromazine on all six parameters selected from an objective rating scale. The author discusses the problems militating against a valid research trial utilizing these medications in this type of patient.Abstract Teaser